Delivery Order SPE2DB24D3014-SPE2DB25FKSJS

Award Date 1/7/25
Potential Completion Date 1/29/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.31 firm fixed-price delivery order is for the provision of Ingrezza 40 mg capsules, a medication used to treat a neurological disorder. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,144.94 delivery order contract is for the supply of Ingrezza 80 mg capsules, a medication used to treat a neurological condition. The contract has a completion date of July 24, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for Ingrezza 80 mg capsules, a specialty medication. The contract has an ultimate completion date of January 14, 2025 and was awarded on December 20, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,099.22 firm fixed-price delivery order contract is for the supply of 60 mg Ingrezza capsules. Ingrezza is a specialty medication used to treat a neurological disorder. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules to the U.S. government. The contract, valued at $10,659.93, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for pharmaceutical products and medical supplies. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for the supply of Ingrezza 40 mg capsules. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,022 firm-fixed price delivery order covers the supply of Ingrezza 60 mg capsules, a specialty medication, to support federal healthcare programs. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.98 Firm Fixed Price Delivery Order is for the supply of 4557322560 - Ingrezza 80 mg capsules, a medication used to treat a rare movement disorder. The contract has an ultimate completion date of June 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of Ingrezza 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $3,553.31, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and supplier to the federal government. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 28, 2024. It is not associated with a set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,049.61 firm fixed-price delivery order is for the supply of the prescription medication Ingrezza (60 mg capsules), with a performance period ending on December 31, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKSJS
    Delivery Order

This federal contract award, valued at $3,676.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ingrezza 40 mg capsules, a medication used to treat certain neurological conditions. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 29, 2025.

Generated 4/8/25, 9:54 AM